Neurovascular coupling preserved in a chronic mouse model of Alzheimer's disease: Methodology is critical
PS Sharp, KE Ameen-Ali, L Boorman… - Journal of Cerebral …, 2020 - journals.sagepub.com
Impaired neurovascular coupling has been suggested as an early pathogenic factor in
Alzheimer's disease (AD), which could serve as an early biomarker of cerebral pathology …
Alzheimer's disease (AD), which could serve as an early biomarker of cerebral pathology …
[HTML][HTML] Impaired hippocampal neurovascular coupling in a mouse model of Alzheimer's disease
L Li, XK Tong, M Hosseini Kahnouei… - Frontiers in …, 2021 - frontiersin.org
Alzheimer's disease (AD), the most common form of dementia, is characterized by neuronal
degeneration and cerebrovascular dysfunction. Increasing evidence indicates that …
degeneration and cerebrovascular dysfunction. Increasing evidence indicates that …
[HTML][HTML] Enhanced cerebral blood volume under normobaric hyperoxia in the J20-hAPP mouse model of Alzheimer's disease
Early impairments to neurovascular coupling have been proposed to be a key pathogenic
factor in the onset and progression of Alzheimer's disease (AD). Studies have shown …
factor in the onset and progression of Alzheimer's disease (AD). Studies have shown …
Assessment of neurovascular coupling and cortical spreading depression in mixed mouse models of atherosclerosis and Alzheimer's disease
Neurovascular coupling is a critical brain mechanism whereby changes to blood flow
accompany localised neural activity. The breakdown of neurovascular coupling is linked to …
accompany localised neural activity. The breakdown of neurovascular coupling is linked to …
Augmentation of sensory-evoked hemodynamic response in an early Alzheimer's disease mouse model
Based on enlarged blood oxygen level-dependent (BOLD) responses in cognitively normal
subjects at risk for Alzheimer's disease (AD), compensatory neuronal hyperactivation has …
subjects at risk for Alzheimer's disease (AD), compensatory neuronal hyperactivation has …
[HTML][HTML] Altered regional cerebral blood flow and brain function across the Alzheimer's disease spectrum: a potential biomarker
Q Zhang, Q Wang, C He, D Fan, Y Zhu… - Frontiers in Aging …, 2021 - frontiersin.org
Objective: To investigate variation in the characteristics of regional cerebral blood flow
(rCBF), brain activity, and intrinsic functional connectivity (FC) across the Alzheimer's …
(rCBF), brain activity, and intrinsic functional connectivity (FC) across the Alzheimer's …
CVN‐AD Alzheimer's mice show premature reduction in neurovascular coupling in response to spreading depression and anoxia compared to aged controls
We compared the efficacy of neurovascular coupling and substrate supply in cerebral cortex
during severe metabolic challenges in transgenic Alzheimer's [CVN‐AD] and control …
during severe metabolic challenges in transgenic Alzheimer's [CVN‐AD] and control …
[HTML][HTML] A pilot study investigating changes in capillary hemodynamics and its modulation by exercise in the APP-PS1 Alzheimer mouse model
Dysfunction in neurovascular coupling that results in a mismatch between cerebral blood
flow and neuronal activity has been suggested to play a key role in the pathogenesis of …
flow and neuronal activity has been suggested to play a key role in the pathogenesis of …
Impaired cerebral autoregulation and vasomotor reactivity in sporadic Alzheimer's disease
A SS Meel-van den Abeelen, J Lagro… - Current Alzheimer …, 2014 - ingentaconnect.com
Background Understanding the relationship between vascular disease and Alzheimer's
disease (AD) will enhance our insight into this disease and pave the way for novel …
disease (AD) will enhance our insight into this disease and pave the way for novel …
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease
Combined evidence from neuroimaging and neuropathological studies shows that signs of
vascular pathology and brain hypoperfusion develop early in Alzheimer's disease (AD). To …
vascular pathology and brain hypoperfusion develop early in Alzheimer's disease (AD). To …